Participants who already own an Apple Watch may be eligible to join the study as well, with certain restrictions.Participation in the study will span a total of three years with two years of active engagement, followed by one year of additional data collection. "And people fear having a stroke as much as dying.
Through the app-based approach, the study will enable participants to engage in the study remotely, right from their iPhone and in some cases an Apple Watch, rather than travel to a clinical trial site. The study is designed to explore if the Heartline™ Study app on iPhone and heart health features on Apple Watch can improve health outcomes, including reducing the … This approach to conducting a clinical trial, if successful, could potentially save time and cost. Eligible participants will be randomized to one of two possible groups.
Per the official Heartline Study app description: “Johnson & Johnson and Apple are committed to ensuring that participation in the study is not limited by financial need.” This site is governed solely by applicable U.S. laws and governmental regulations. He added that one group of patients will be tracked only on their phones and another group will receive an Apple Watch that will feature an ECG app and irregular rhythm notification feature.The J&J-Apple announcement is the latest in a partnership between the two companies. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC.
Apple Working With Johnson & Johnson on 'Heartline Study' Aimed at Reducing Risk of Stroke Tuesday February 25, 2020 5:10 am PST by Mitchel Broussard Apple and Johnson & Johnson … This site is governed solely by applicable U.S. laws and governmental regulations. “The Heartline Study is a nationwide, randomized, controlled, app-based, virtual research study sponsored by Janssen Pharmaceuticals, Inc., a member of the Janssen … All contents © Copyright Johnson & Johnson Services, Inc.1997-2020. “The Heartline™ Study will help further understanding of how our technology could both contribute to science and help improve health outcomes, including reducing the risk of stroke.”To be eligible for the study, participants must be age 65 or older, a resident of the United States for the duration of the study, have Original (traditional) Medicare, have an iPhone 6s or a later model (with iOS version 12.2 or later), and agree to provide access to their Medicare claims data.
You are now leaving jnj.com. They first announced plans to work together on an AFib detection study in January 2019.Apple has been promoting the Apple Watch as a device that can help people keep track of vital medical information, most notably their heart rate. All content of the Dow Jones branded indices Copyright S&P Dow Jones Indices LLC 2018 and/or its affiliates.Medical robots keeping watch over coronavirus patientsNavarro: This is the issue with Microsoft potentially buying TikTokFiery exchange erupts at congressional antitrust hearingUnder questioning, Zuckerberg admits Instagram was a 'competitor'Congresswoman grills Facebook CEO on copying competitorsRussian misinformation isn't new.
Heartline is a research study exploring how everyday technology like the iPhone and Apple Watch can enable earlier detection of atrial fibrillation (AFib), a leading cause of stroke. All Rights Reserved. Apple and Johnson & Johnson announced this morning the launch of their new digital health study exploring the impact of Apple’s devices and a study-specific engagement program on cardiovascular outcomes among the Medicare population. All times are ET. This approach to conducting a clinical trial, if successful, could potentially save time and cost. "Heartline could go down as a landmark clinical trial.
Advancing New Healthcare Solutions Through CollaborationLearn About the Company's Rich Heritage at Our Digital Museum